Focus on Nursing Pharmacology, 8th Edition – Complete Test
Bank (Ch. 1–59) 2025/2026 | Full Pack A+ Graded & Instant
Download
1. The study of what the body does to a drug is known as:
A. Pharmacodynamics
B. Pharmacotherapeutics
C. Pharmacokinetics
D. Pharmacogenetics
2. The first-pass effect significantly reduces the bioavailability
of a drug administered via which route?
A. Intravenous
B. Sublingual
C. Oral
D. Transdermal
3. A drug with a high therapeutic index is generally
considered:
A. Highly toxic and requires close monitoring
B. Safe and requires less monitoring
C. Effective only for a narrow range of conditions
D. Unsuitable for human use
4. The primary site of drug metabolism in the body is the:
A. Kidneys
B. Liver
,C. Lungs
D. Stomach
5. What does the term "half-life" of a drug refer to?
A. The time it takes for a drug to show its therapeutic effect
B. The time it takes for half of the drug to be eliminated from
the body
C. The time it takes for a drug to be fully absorbed
D. The duration of the drug's action
6. When two drugs are given together and their combined
effect is greater than the sum of their individual effects, this is
called:
A. Antagonism
B. Synergism
C. Potentiation
D. Tolerance
7. The phase of clinical drug testing that involves a small
number of healthy volunteers to determine safe dosage and
pharmacokinetics is:
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
8. A patient with hepatic cirrhosis would be at risk for which
pharmacokinetic alteration?
,A. Increased drug metabolism
B. Decreased drug metabolism
C. Increased drug excretion
D. Decreased drug absorption
9. The nursing process in pharmacology includes which of the
following steps? (Select all that apply)
A. Assessment
B. Diagnosis
C. Prescription
D. Implementation
E. Evaluation
10. A teratogenic drug is one that:
A. Causes cancer
B. Causes birth defects
C. Is highly addictive
D. Causes organ toxicity
Nursing Pharmacology: Chapters 11-20 (Autonomic and
Neuropharmacology)
11. A patient receiving a beta-blocker like metoprolol should
be monitored for:
A. Tachycardia and hypertension
B. Bradycardia and hypotension
, C. Bronchodilation
D. Hypoglycemia
12. Which drug is a direct-acting cholinergic agonist used to
treat myasthenia gravis?
A. Atropine
B. Neostigmine
C. Prazosin
D. Epinephrine
13. The preferred treatment for anaphylactic shock is:
A. Albuterol
B. Diphenhydramine
C. Epinephrine
D. Prednisone
14. A common side effect of Atrovent (ipratropium), an
anticholinergic inhaler, is:
A. Dry mouth
B. Diarrhea
C. Bronchospasm
D. Tachycardia
15. Levodopa is used in the management of Parkinson's
disease because it:
A. Blocks dopamine receptors in the brain
B. Is a precursor to dopamine that can cross the blood-brain
Bank (Ch. 1–59) 2025/2026 | Full Pack A+ Graded & Instant
Download
1. The study of what the body does to a drug is known as:
A. Pharmacodynamics
B. Pharmacotherapeutics
C. Pharmacokinetics
D. Pharmacogenetics
2. The first-pass effect significantly reduces the bioavailability
of a drug administered via which route?
A. Intravenous
B. Sublingual
C. Oral
D. Transdermal
3. A drug with a high therapeutic index is generally
considered:
A. Highly toxic and requires close monitoring
B. Safe and requires less monitoring
C. Effective only for a narrow range of conditions
D. Unsuitable for human use
4. The primary site of drug metabolism in the body is the:
A. Kidneys
B. Liver
,C. Lungs
D. Stomach
5. What does the term "half-life" of a drug refer to?
A. The time it takes for a drug to show its therapeutic effect
B. The time it takes for half of the drug to be eliminated from
the body
C. The time it takes for a drug to be fully absorbed
D. The duration of the drug's action
6. When two drugs are given together and their combined
effect is greater than the sum of their individual effects, this is
called:
A. Antagonism
B. Synergism
C. Potentiation
D. Tolerance
7. The phase of clinical drug testing that involves a small
number of healthy volunteers to determine safe dosage and
pharmacokinetics is:
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
8. A patient with hepatic cirrhosis would be at risk for which
pharmacokinetic alteration?
,A. Increased drug metabolism
B. Decreased drug metabolism
C. Increased drug excretion
D. Decreased drug absorption
9. The nursing process in pharmacology includes which of the
following steps? (Select all that apply)
A. Assessment
B. Diagnosis
C. Prescription
D. Implementation
E. Evaluation
10. A teratogenic drug is one that:
A. Causes cancer
B. Causes birth defects
C. Is highly addictive
D. Causes organ toxicity
Nursing Pharmacology: Chapters 11-20 (Autonomic and
Neuropharmacology)
11. A patient receiving a beta-blocker like metoprolol should
be monitored for:
A. Tachycardia and hypertension
B. Bradycardia and hypotension
, C. Bronchodilation
D. Hypoglycemia
12. Which drug is a direct-acting cholinergic agonist used to
treat myasthenia gravis?
A. Atropine
B. Neostigmine
C. Prazosin
D. Epinephrine
13. The preferred treatment for anaphylactic shock is:
A. Albuterol
B. Diphenhydramine
C. Epinephrine
D. Prednisone
14. A common side effect of Atrovent (ipratropium), an
anticholinergic inhaler, is:
A. Dry mouth
B. Diarrhea
C. Bronchospasm
D. Tachycardia
15. Levodopa is used in the management of Parkinson's
disease because it:
A. Blocks dopamine receptors in the brain
B. Is a precursor to dopamine that can cross the blood-brain
